Evora PR - Search Results

1

Catastrophic cardiovascular adverse reactions to protamine are nitric oxide/cyclic guanosine monophosphate dependent and endothelium mediated: should methylene blue be the treatment of choice?

Viaro F, Dalio MB, Evora PR. Viaro F, et al. Among authors: evora pr. Chest. 2002 Sep;122(3):1061-6. doi: 10.1378/chest.122.3.1061. Chest. 2002. PMID: 12226053

2

Effect of arginine vasopressin on the canine epicardial coronary artery: experiments on V1-receptor-mediated production of nitric oxide.

Evora PR, Pearson PJ, Rodrigues AJ, Viaro F, Schaff HV. Evora PR, et al. Arq Bras Cardiol. 2003 May;80(5):483-94. doi: 10.1590/s0066-782x2003000500002. Epub 2003 May 30. Arq Bras Cardiol. 2003. PMID: 12792714 Free article. English, Portuguese.

3

The cytoprotective effect of a nitric oxide donor drug on gastric mucous membrane of rats treated with ketoprofen, a non-steroidal anti-inflammatory drug.

Villa AL, Reginaldo C, Viaro F, Ramalho F, Campos AD, Evora PR. Villa AL, et al. Among authors: evora pr. Arq Gastroenterol. 2006 Jul-Sep;43(3):233-7. doi: 10.1590/s0004-28032006000300015. Arq Gastroenterol. 2006. PMID: 17160241 Free article.

4

In vitro pharmacological study of femoral artery vascular reactivity after inferior canine hindlimb ischemia/reperfusion: effects of in vivo nitric oxide blocker infusion.

Joviliano EE, Piccinato CE, Cherri J, Viaro F, Moryia T, Celotto AC, Bonaventura D, Evora PR. Joviliano EE, et al. Among authors: evora pr. Ann Vasc Surg. 2007 Sep;21(5):618-28. doi: 10.1016/j.avsg.2007.07.004. Ann Vasc Surg. 2007. PMID: 17823044

5

Compound 48/80 induces endothelium-dependent and histamine release-independent relaxation in rabbit aorta.

Viaro F, Celotto AC, Capellini VK, Baldo CF, Rodrigues AJ, Vicente WV, Evora PR. Viaro F, et al. Among authors: evora pr. Nitric Oxide. 2008 Mar;18(2):87-92. doi: 10.1016/j.niox.2007.11.004. Epub 2007 Nov 28. Nitric Oxide. 2008. PMID: 18078832

6

Pharmacology of the human saphenous vein.

Joviliano EE, Dellalibera-Joviliano R, Celotto AC, Capellini VK, Dalio MB, Picconato CE, Evora PR. Joviliano EE, et al. Among authors: evora pr. Curr Vasc Pharmacol. 2011 Jul 1;9(4):501-20. doi: 10.2174/157016111796197260. Curr Vasc Pharmacol. 2011. PMID: 21143161 Review.

7

Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.

Farina Junior JA, Celotto AC, da Silva MF, Evora PR. Farina Junior JA, et al. Among authors: evora pr. Med Sci Monit. 2012 May;18(5):HY13-7. doi: 10.12659/msm.882718. Med Sci Monit. 2012. PMID: 22534716 Free PMC article. Review.

8

Methylene Blue and Cardiovascular Collapse.

Evora PR. Evora PR. J Emerg Med. 2016 Jan;50(1):126-7. doi: 10.1016/j.jemermed.2015.03.045. Epub 2015 Oct 24. J Emerg Med. 2016. PMID: 26603363 No abstract available.

9

Methylene Blue Is a Guanylate Cyclase Inhibitor That Does Not Interfere with Nitric Oxide Synthesis.

Evora PR. Evora PR. Tex Heart Inst J. 2016 Feb 1;43(1):103. doi: 10.14503/THIJ-15-5629. eCollection 2016 Feb. Tex Heart Inst J. 2016. PMID: 27047301 Free PMC article. No abstract available.

10

Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric Diseases.

Batista-Filho MM, Kandratavicius L, Nunes EA, Tumas V, Colli BO, Hallak JE, Maia-de-Oliveira JP, Evora PR. Batista-Filho MM, et al. Among authors: evora pr. CNS Neurol Disord Drug Targets. 2016;15(8):976-986. doi: 10.2174/1871527315666160720120326. CNS Neurol Disord Drug Targets. 2016. PMID: 27450870 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

309 results

Search Page